Endeavours to vaccinate the poorest international locations towards Covid-19 have slowed to a trickle, leaving many with weakened defenses towards...
slowed
US infectious ailments agency BARDA is supporting to fund the trial with a grant value up to $72.5mln. (NASDAQ:SMMT) explained...